161 related articles for article (PubMed ID: 17392157)
1. Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.
Gianella A; Nobili E; Abbate M; Zoja C; Gelosa P; Mussoni L; Bellosta S; Canavesi M; Rottoli D; Guerrini U; Brioschi M; Banfi C; Tremoli E; Remuzzi G; Sironi L
Am J Pathol; 2007 Apr; 170(4):1165-77. PubMed ID: 17392157
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).
de Barros EP; Garcia-Pinto AB; Machado PY; dos Santos Pereira MJ; de Carvalho JJ
J Mol Histol; 2011 Aug; 42(4):323-31. PubMed ID: 21670990
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin-induced arrest in progression of renal disease.
Vidt DG; Cressman MD; Harris S; Pears JS; Hutchinson HG
Cardiology; 2004; 102(1):52-60. PubMed ID: 15073451
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin protects against podocyte apoptosis in vitro.
Cormack-Aboud FC; Brinkkoetter PT; Pippin JW; Shankland SJ; Durvasula RV
Nephrol Dial Transplant; 2009 Feb; 24(2):404-12. PubMed ID: 18820279
[TBL] [Abstract][Full Text] [Related]
7. Yellow wine polyphenolic compounds inhibit matrix metalloproteinase-2, -9 expression and improve atherosclerotic plaque in LDL-receptor-knockout mice.
Zhai X; Chi J; Tang W; Ji Z; Zhao F; Jiang C; Lv H; Guo H
J Pharmacol Sci; 2014; 125(2):132-41. PubMed ID: 24859779
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.
Shi YF; Chi JF; Tang WL; Xu FK; Liu LB; Ji Z; Lv HT; Guo HY
J Zhejiang Univ Sci B; 2013 Aug; 14(8):696-704. PubMed ID: 23897788
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
Chang SA; Kim YJ; Lee HW; Kim DH; Kim HK; Chang HJ; Sohn DW; Oh BH; Park YB
Hypertension; 2009 Sep; 54(3):591-7. PubMed ID: 19564547
[TBL] [Abstract][Full Text] [Related]
11. Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.
Gelosa P; Ballerio R; Banfi C; Nobili E; Gianella A; Pignieri A; Brioschi M; Guerrini U; Castiglioni L; Blanc-Guillemaud V; Lerond L; Tremoli E; Sironi L
J Pharmacol Exp Ther; 2010 Jul; 334(1):199-205. PubMed ID: 20332187
[TBL] [Abstract][Full Text] [Related]
12. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
Sicard P; Lauzier B; Oudot A; Busseuil D; Collin B; Duvillard L; Moreau D; Vergely C; Rochette L
Arch Mal Coeur Vaiss; 2005; 98(7-8):804-8. PubMed ID: 16220751
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin attenuates inflammation, apoptosis and fibrosis in a rat model of cyclosporine-induced nephropathy.
Nam HK; Lee SJ; Kim MH; Rho JH; Son YK; Lee SM; Kim SE; Kim KH; An WS
Am J Nephrol; 2013; 37(1):7-15. PubMed ID: 23258196
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
Whaley-Connell A; Habibi J; Nistala R; Cooper SA; Karuparthi PR; Hayden MR; Rehmer N; DeMarco VG; Andresen BT; Wei Y; Ferrario C; Sowers JR
Hypertension; 2008 Feb; 51(2):474-80. PubMed ID: 18172055
[TBL] [Abstract][Full Text] [Related]
15. Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?
Marzoll A; Melchior-Becker A; Cipollone F; Fischer JW
J Cell Mol Med; 2011 Feb; 15(2):232-43. PubMed ID: 20015203
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agents.
Capra V; Rovati GE
Pulm Pharmacol Ther; 2014 Feb; 27(1):10-6. PubMed ID: 23806820
[TBL] [Abstract][Full Text] [Related]
17. Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats.
Sicard P; Acar N; Grégoire S; Lauzier B; Bron AM; Creuzot-Garcher C; Bretillon L; Vergely C; Rochette L
Br J Pharmacol; 2007 Aug; 151(7):979-86. PubMed ID: 17572703
[TBL] [Abstract][Full Text] [Related]
18. Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats.
Sicard P; Delemasure S; Korandji C; Segueira-Le Grand A; Lauzier B; Guilland JC; Duvillard L; Zeller M; Cottin Y; Vergely C; Rochette L
Free Radic Res; 2008 Mar; 42(3):226-36. PubMed ID: 18344117
[TBL] [Abstract][Full Text] [Related]
19. Plasmin is not protective in experimental renal interstitial fibrosis.
Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
[TBL] [Abstract][Full Text] [Related]
20. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
